Tumor necrosis factor-α and tumor growth factor-β1 genotype: Partial association with intragraft gene expression in two cases of long-term peripheral tolerance to a kidney transplant

Transplantation

Volumn 69, Issue 7, 2000, Pages 1527-1530

  Burlingham, William J ^a,d   O'Connell, Peta J ^b   Jacobson, Lynn M ^a   Becker, Bryan N ^a   Kirk, Allan D ^c   Pravica, Vera ^e   Hutchinson, Ian V ^e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e University of Wisconsin ^*

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0034655329     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00058     Document Type: Article

References (10)

1. Burlingham WJ, Kusaka S, Chin LT, et al. Focal infiltrates in kidney allografts: developing a model for clinical transplant tolerance. Graft 1999; 2 (6): 253.
2. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340 (4): 253.
3. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93 (6): 2431.
4. Kirk AD, Jacobson LM, Heisey DM, Fass NA, Sollinger HW, Pirsch JD. Post-transplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription. Transplantation 1997; 64 (12): 1716.
5. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397 (6719): 530.
6. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995; 59: 1147.
7. Perrey C, Pravica V, Sinnott PJ, Hutchinson TV. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transplant Immunol 1998; 6 (3): 193.
8. Burlingham WJ. Chimerism after organ transplantation: is there any clinical significance? Clin Transplant 1996; 10 (1 Pt 2): 110.
9. Becker BN, Jacobson LM, Becker YT, et al. Renin-angiotensin system gene expression in posttransplant hypertension predicts allograft function. Transplantation, 2000; 69: 1485.
10. Kusaka S, Grailer AP, Fechner JH, Jr., et al. Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient. J Immunol 2000; 164: 2240.